Retatrutide
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 10000
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Retatrutide | Atherosclerotic Cardiovascular Disease (ASCVD... | n/r | n/r | n/r | n/r |
| Placebo | Atherosclerotic Cardiovascular Disease (ASCVD... | n/r | n/r | n/r | n/r |